Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Quantitative PCR: an alternative approach to detect common copy number alterations in multiple myeloma.

Chillón MC, Jiménez C, García-Sanz R, Alcoceba M, Prieto I, García-Alvarez M, Antón A, Maldonado R, Hernández-Ruano M, González M, Gutiérrez NC, Sarasquete ME.

Ann Hematol. 2017 Oct;96(10):1699-1705. doi: 10.1007/s00277-017-3083-x. Epub 2017 Aug 2.

PMID:
28770277
2.

Identification of 13q deletion, trisomy 1q, and IgH rearrangement as the most frequent chromosomal changes found in Korean patients with multiple myeloma.

Bang SM, Kim YR, Cho HI, Chi HS, Seo EJ, Park CJ, Yoo SJ, Kim HC, Chun HG, Min HC, Oh BR, Kim TY, Lee JH, Lee DS.

Cancer Genet Cytogenet. 2006 Jul 15;168(2):124-32.

PMID:
16843102
3.

[Correlation between chromosome 13q14 deletion and 1q abnormality in multiple myeloma].

Chen LJ, Li JY, Zhu Y, Wang XW, Qiu HR, Yang RF, Xu W, Xu JR, Lu H.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009 Feb;26(1):102-5. doi: 10.3760/cma.j.issn.1003-9406.2009.01.024. Chinese.

PMID:
19199264
4.

Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy.

Fonseca R, Oken MM, Harrington D, Bailey RJ, Van Wier SA, Henderson KJ, Kay NE, Van Ness B, Greipp PR, Dewald GW.

Leukemia. 2001 Jun;15(6):981-6.

PMID:
11417487
5.

Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.

Rasillo A, Tabernero MD, Sánchez ML, Pérez de Andrés M, Martín Ayuso M, Hernández J, Moro MJ, Fernández-Calvo J, Sayagués JM, Bortoluci A, San Miguel JF, Orfao A.

Cancer. 2003 Feb 1;97(3):601-9.

6.

Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.

Chen L, Li J, Xu W, Qiu H, Zhu Y, Zhang Y, Duan L, Qian S, Lu H.

Exp Oncol. 2007 Jun;29(2):116-20.

PMID:
17704743
7.

Detection of chromosome 13q deletions and IgH translocations in patients with multiple myeloma by FISH: comparison with karyotype analysis.

Chang H, Li D, Zhuang L, Nie E, Bouman D, Stewart AK, Chun K.

Leuk Lymphoma. 2004 May;45(5):965-9.

PMID:
15291356
8.

Chromosome 13q deletion and IgH abnormalities may be both masked by near-tetraploidy in a high proportion of multiple myeloma patients: a combined morphology and I-FISH analysis.

Koren-Michowitz M, Hardan I, Berghoff J, Yshoev G, Amariglio N, Rechavi G, Nagler A, Trakhtenbrot L.

Cancer Lett. 2007 Oct 8;255(2):307-14. Epub 2007 Jun 27.

PMID:
17590504
9.

Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.

Wu KL, Beverloo B, Lokhorst HM, Segeren CM, van der Holt B, Steijaert MM, Westveer PH, Poddighe PJ, Verhoef GE, Sonneveld P; Dutch-Belgian Haemato-Oncology Cooperative Study Group (HOVON); Dutch Working Party on Cancer Genetics and Cytogenetics (NWCGC).

Br J Haematol. 2007 Feb;136(4):615-23.

PMID:
17223915
10.

[Cytogenetic abnormalities and prognosis of 532 patients with multiple myeloma].

Wu H, Zhang H, He HY, Jiang H, Zhao YY, An R, He J, Li R, Lu J, Hou J.

Zhonghua Xue Ye Xue Za Zhi. 2017 Sep 14;38(9):739-743. doi: 10.3760/cma.j.issn.0253-2727.2017.09.002. Chinese.

PMID:
29081188
11.

Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myeloma.

Kaufmann H, Krömer E, Nösslinger T, Weltermann A, Ackermann J, Reisner R, Bernhart M, Drach J.

Eur J Haematol. 2003 Sep;71(3):179-83.

PMID:
12930318
12.

Prognostic power of abnormal cytogenetics for multiple myeloma: a multicenter study in China.

Lai YY, Huang XJ, Cai Z, Cao XS, Chen FP, Chen XQ, Chen BA, Fang MY, Feng JF, Fu WL, Guo HY, Hou M, Hou J, Hu Y, Hu XT, Hu XM, Huang LQ, Jin J, Li JY, Li J, Li W, Liang YM, Liu T, Liu QF, Liu YH, Mao P, Ouyang J, Qiu LG, Qiu L, Shao CK, Shi B, Song YP, Sun ZM, Wang QS, Wang C, Wang JM, Wang YS, Wang Z, Wu JB, Wu YX, Xia RX, Xue YQ, Yang BZ, Yang G, Yang ZL, Yu L, Yuan Z, Zhang S, Zhang Y, Zhao HG, Zhao L, Zhou DB, Zou SH, Zhu YF.

Chin Med J (Engl). 2012 Aug;125(15):2663-70.

PMID:
22931972
13.

Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India.

Kadam Amare PS, Jain H, Nikalje S, Sengar M, Menon H, Inamdar N, Subramanian PG, Gujral S, Shet T, Epari S, Nair R.

Indian J Med Res. 2016 Oct;144(4):536-543. doi: 10.4103/0971-5916.200890.

14.

Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.

Königsberg R, Zojer N, Ackermann J, Krömer E, Kittler H, Fritz E, Kaufmann H, Nösslinger T, Riedl L, Gisslinger H, Jäger U, Simonitsch I, Heinz R, Ludwig H, Huber H, Drach J.

J Clin Oncol. 2000 Feb;18(4):804-12.

PMID:
10673522
15.

Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance.

Königsberg R, Ackermann J, Kaufmann H, Zojer N, Urbauer E, Krömer E, Jäger U, Gisslinger H, Schreiber S, Heinz R, Ludwig H, Huber H, Drach J.

Leukemia. 2000 Nov;14(11):1975-9.

PMID:
11069034
16.

[Genetic abnormalities in multiple myeloma: role in oncogenesis and impact on survival].

Decaux O, Lodé L, Minvielle S, Avet-Loiseau H.

Rev Med Interne. 2007 Oct;28(10):677-81. Epub 2007 May 25. Review. French.

PMID:
17559979
17.

Gains of 13q are correlated with a poor prognosis in liposarcoma.

Schmidt H, Bartel F, Kappler M, Würl P, Lange H, Bache M, Holzhausen HJ, Taubert H.

Mod Pathol. 2005 May;18(5):638-44.

18.

Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization.

Slovak ML, Bedell V, Pagel K, Chang KL, Smith D, Somlo G.

Cancer Genet Cytogenet. 2005 Apr 15;158(2):99-109.

PMID:
15796956
19.

[Application of fluorescence in-situ hybridization technique in multiple myeloma].

Zhao Y, Zheng D, Li J, Zhu WT.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2009 Sep;38(5):459-64. Chinese.

PMID:
19830857
20.

Chromosome 1 abnormalities in multiple myeloma.

Marzin Y, Jamet D, Douet-Guilbert N, Morel F, Le Bris MJ, Morice P, Abgrall JF, Berthou C, De Braekeleer M.

Anticancer Res. 2006 Mar-Apr;26(2A):953-9.

Supplemental Content

Support Center